These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 3864002)
1. [Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: melanoma, carcinoma, chronic and acute lymphatic leukemia]. Gabrilovac J Lijec Vjesn; 1985 Aug; 107(8):323-6. PubMed ID: 3864002 [No Abstract] [Full Text] [Related]
2. [Natural killer activity in patients with malignant melanoma]. Masserini C; Villa ML; Rovini D; Clerici E Boll Ist Sieroter Milan; 1981; 60(4):307-15. PubMed ID: 7326104 [TBL] [Abstract][Full Text] [Related]
3. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma. Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076 [TBL] [Abstract][Full Text] [Related]
4. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients. Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567 [TBL] [Abstract][Full Text] [Related]
5. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells. Pattengale PK; Sundstrom C; Yu AL; Levine A Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer. Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells. Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688 [TBL] [Abstract][Full Text] [Related]
8. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission. Inada M; Okawa H; Suzuki M; Yata J Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376 [TBL] [Abstract][Full Text] [Related]
9. Social support, psychological distress, and natural killer cell activity in ovarian cancer. Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594 [TBL] [Abstract][Full Text] [Related]
10. Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients. Hersey P; Hobbs A; Edwards A; McCarthy WH; McGovern VJ Cancer Res; 1982 Jan; 42(1):363-8. PubMed ID: 7053864 [TBL] [Abstract][Full Text] [Related]
11. Decreased natural killer cell activity in children with untreated acute leukemia. Nasrallah AG; Miale TD Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019 [TBL] [Abstract][Full Text] [Related]
12. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies]. Graul A; Orfanos CE Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439 [TBL] [Abstract][Full Text] [Related]
14. Natural killer (NK) activity in children with acute lymphoblastic leukemia. Tanaka Y Hiroshima J Med Sci; 1981 Jun; 30(2):127-33. PubMed ID: 6946050 [No Abstract] [Full Text] [Related]
15. Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ. Introna M; Allavena P; Biondi A; Colombo N; Villa A; Mantovani A J Natl Cancer Inst; 1983 Jan; 70(1):21-6. PubMed ID: 6337291 [TBL] [Abstract][Full Text] [Related]
16. Human natural killer cells: a comprehensive review. Sinkovics JG; Horvath JC Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642 [TBL] [Abstract][Full Text] [Related]
17. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348 [TBL] [Abstract][Full Text] [Related]
18. Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia. Rümke HC; Miedema F; ten Berge IJ; Terpstra F; van der Reijden HJ; van de Griend RJ; de Bruin HG; von dem Borne AE; Smit JW; Zeijlemaker WP; Melief CJ J Immunol; 1982 Jul; 129(1):419-26. PubMed ID: 6211484 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Sharma B; Vaziri ND Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041 [TBL] [Abstract][Full Text] [Related]